Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rose

Showing results (181-190 of 227) with videos related to

Pageof 23
Sort By:
AHP Journal|June 15, 2006
AHP thought leaders forum. The next decade in health care and health care philanthropy. Part 2Gene Attal, Lenox Baker, June Bradham, et al.
Clinical Epigenetics|February 16, 2018
Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: <i>RBBP8</i>/<i>CtIP</i> is almost exclusively methylated in bladder cancerJolein Mijnes, Jürgen Veeck, Nadine T Gaisa, et al.
Cancers|February 15, 2022
ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In VitroMichael Rose, Sebastian Huth, Marc Wiesehöfer, et al.
Plos One|April 16, 2015
AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detectionStefan Garczyk, Saskia von Stillfried, Wiebke Antonopoulos, et al.
International Journal of Biological Macromolecules|October 18, 2025
Characterization of ITIH6, a novel inter-α-inhibitor family member with prognostic significance in cholangiocarcinomaJia-Xin Shi, Michael Rose, Lara Heij, et al.
Pathologie (Heidelberg, Germany)|November 26, 2025
POLQ and DNA-PK inhibition in muscle-invasive bladder cancer : Enhancing radiosensitivity with novel DNA damage response inhibitors to improve radiotherapy outcomesJulia Pannhausen, Ahmed A Chughtai, Michael K Melzer, et al.
Genes|November 24, 2020
SWI/SNF Alterations in Squamous Bladder CancersFabian Achenbach, Michael Rose, Nadina Ortiz-Brüchle, et al.
FEBS Open Bio|December 13, 2025
Tumor-stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancerSophie Leypold, Janik Riese, Lancelot Seillier, et al.
Genes|July 2, 2021
Molecular Characterization of Muellerian Tumors of the Urinary TractNadina Ortiz-Brüchle, Sophie Wucherpfennig, Michael Rose, et al.
BMJ Open|March 6, 2021
Being Your Best: protocol for a feasibility study of a codesigned approach to reduce symptoms of frailty in people aged 65 years or more after transition from hospitalJudy A Lowthian, Maja Green, Claudia Meyer, et al.
Pageof 23

Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
AHP Journal|June 15, 2006
AHP thought leaders forum. The next decade in health care and health care philanthropy. Part 2Gene Attal, Lenox Baker, June Bradham, et al.
Clinical Epigenetics|February 16, 2018
Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: <i>RBBP8</i>/<i>CtIP</i> is almost exclusively methylated in bladder cancerJolein Mijnes, Jürgen Veeck, Nadine T Gaisa, et al.
Cancers|February 15, 2022
ITIH5-Derived Polypeptides Covering the VIT Domain Suppress the Growth of Human Cancer Cells In VitroMichael Rose, Sebastian Huth, Marc Wiesehöfer, et al.
Plos One|April 16, 2015
AGR3 in breast cancer: prognostic impact and suitable serum-based biomarker for early cancer detectionStefan Garczyk, Saskia von Stillfried, Wiebke Antonopoulos, et al.
International Journal of Biological Macromolecules|October 18, 2025
Characterization of ITIH6, a novel inter-α-inhibitor family member with prognostic significance in cholangiocarcinomaJia-Xin Shi, Michael Rose, Lara Heij, et al.
Pathologie (Heidelberg, Germany)|November 26, 2025
POLQ and DNA-PK inhibition in muscle-invasive bladder cancer : Enhancing radiosensitivity with novel DNA damage response inhibitors to improve radiotherapy outcomesJulia Pannhausen, Ahmed A Chughtai, Michael K Melzer, et al.
Genes|November 24, 2020
SWI/SNF Alterations in Squamous Bladder CancersFabian Achenbach, Michael Rose, Nadina Ortiz-Brüchle, et al.
FEBS Open Bio|December 13, 2025
Tumor-stromal crosstalk and macrophage enrichment are associated with chemotherapy response in bladder cancerSophie Leypold, Janik Riese, Lancelot Seillier, et al.
Genes|July 2, 2021
Molecular Characterization of Muellerian Tumors of the Urinary TractNadina Ortiz-Brüchle, Sophie Wucherpfennig, Michael Rose, et al.
BMJ Open|March 6, 2021
Being Your Best: protocol for a feasibility study of a codesigned approach to reduce symptoms of frailty in people aged 65 years or more after transition from hospitalJudy A Lowthian, Maja Green, Claudia Meyer, et al.
Pageof 23